Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
ATNM
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w low +24.0%
ATNM
Actinium Pharmaceuticals, Inc
☁️ News word cloud
Top words across the last 50 articles for this ticker.
nasdaq
actinium
pharmaceuticals
trading
class
rating
action
period
compared
nyse
high
last
investors
close
lawsuit
market
price
previous
against
after
StonvexStonvexStonvexStonvex